Both self-selected groups did not differ in general satisfaction with labor and delivery at all three time points after birth despite a significantly higher experienced pain in the RPCA group.
(Acta Obstet Gynecol Scand. 2015;94(9):1014–1021)
Remifentanil is a short-acting opioid that is able to metabolize quickly through nonspecific tissue esterases with peak onset at 60 to 90 seconds. Patient-controlled remifentanil is now used for labor analgesia on some units, and several studies have positively evaluated the safety and efficacy of its use. However, it is associated with infrequent but serious side effects impacting patient respiration. Epidural analgesia is currently seen as the best option for labor analgesia, but it carries its own side effects, including postdural puncture headache, hypotension, an increased risk for instrumental deliveries, and increased body temperature that can make maternal infections more difficult to detect. The authors of this study compared these 2 methods of analgesia according to levels of patient satisfaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.